A Global Perspective on Emerging BTK Inhibitor Therapy Data for Relapsed/Refractory CLL and MCL in 2022*

Review expert perspectives and insights on the most clinically relevant data for chronic lymphocytic leukemia and mantle cell lymphoma presented at the 2022 Annual Meetings of ASCO, EHA, Pan Pacific Lymphoma Conference, ESMO, and SOHO.

Othman Al-Sawaf, MD Matthew S. Davids, MD, MMSc Toby Eyre, MBChB, MD Christopher R. Flowers, MD, MS Brad S. Kahl, MD Kami Maddocks, MD Anthony Mato, MD, MSCE Lydia Scarfò, MD Julie M. Vose, MD, MBA Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Released: December 16, 2022 Expired: No longer available for credit

Examiner les points de vue et les idées des experts sur les données les plus pertinentes sur le plan clinique pour le traitement de la leucémie lymphoïde chronique et du lymphome à cellules du manteau présentées lors des réunions annuelles de 2022 de l’ASCO, de l’EHA, de la Pan Pacific Lymphoma Conference, de l’ESMO et de la SOHO.

Othman Al-Sawaf, MD Matthew S. Davids, MD, MMSc Toby Eyre, MBChB, MD Christopher R. Flowers, MD, MS Brad S. Kahl, MD Kami Maddocks, MD Anthony Mato, MD, MSCE Lydia Scarfò, MD Julie M. Vose, MD, MBA Released: January 13, 2023

Erkenntnisse und Perspektiven von Experten zu klinisch relevanten Daten bei chronischer lymphatischer Leukämie und Mantelzell-Lymphom, die auf den Jahresversammlungen der ASCO, EHA, Pan Pacific Lymphoma Conference, ESMO und SOHO vorgestellt wurden.

Othman Al-Sawaf, MD Matthew S. Davids, MD, MMSc Toby Eyre, MBChB, MD Christopher R. Flowers, MD, MS Brad S. Kahl, MD Kami Maddocks, MD Anthony Mato, MD, MSCE Lydia Scarfò, MD Julie M. Vose, MD, MBA Released: January 13, 2023

Analisi delle prospettive e le intuizioni degli esperti sui dati più rilevanti dal punto di vista clinico per la leucemia linfatica cronica e il linfoma a cellule mantellari, presentati ai Congressi annuali 2022 di ASCO, EHA, Pan Pacific Lymphoma Conference, ESMO e SOHO.

Othman Al-Sawaf, MD Matthew S. Davids, MD, MMSc Toby Eyre, MBChB, MD Christopher R. Flowers, MD, MS Brad S. Kahl, MD Kami Maddocks, MD Anthony Mato, MD, MSCE Lydia Scarfò, MD Julie M. Vose, MD, MBA Released: January 13, 2023

Analise as perspectivas e os insights de especialistas sobre os dados clinicamente mais relevantes para leucemia linfocítica crônica e linfoma de células do manto apresentados nas Reuniões Anuais de 2022 da ASCO, EHA, Conferência Pan-Pacífico sobre Linfomas, ESMO e SOHO.

Othman Al-Sawaf, MD Matthew S. Davids, MD, MMSc Toby Eyre, MBChB, MD Christopher R. Flowers, MD, MS Brad S. Kahl, MD Kami Maddocks, MD Anthony Mato, MD, MSCE Lydia Scarfò, MD Julie M. Vose, MD, MBA Released: January 13, 2023

Lea las opiniones y comentarios expertos sobre los datos de mayor relevancia clínica de la leucemia linfocítica crónica y el linfoma de células del manto presentados en las Juntas Anuales de ASCO, EHA, la Conferencia Pan-Pacífico sobre Linfomas, ESMO y SOHO de 2022.

Othman Al-Sawaf, MD Matthew S. Davids, MD, MMSc Toby Eyre, MBChB, MD Christopher R. Flowers, MD, MS Brad S. Kahl, MD Kami Maddocks, MD Anthony Mato, MD, MSCE Lydia Scarfò, MD Julie M. Vose, MD, MBA Released: January 23, 2023